Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alan Garber

Internal Medicine Cambridge, MA Medical Doctor

NPI 1225124787 CMS profile 55204

11 Harvard Yard, Massachusetts Hall, Cambridge, MA 02138

Open in the dashboard

General payments

$4,898,073

392 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$764,109

2 holdings reported · through program year 2025

Through program year 2025, Alan Garber of Cambridge, MA is reported in the CMS Open Payments database as having received $4,898,073 across 392 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $764,109 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $80,156 3
2024 General $654,479 76
2023 General $653,902 93
2022 General $608,430 65
2021 General $954,938 36
2020 General $958,634 29
2019 General $987,535 90
2023 Ownership $400,667 1
2022 Ownership $363,442 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alan Garber
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Alan Garber were reported at $80,156. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Alan Garber Internal Medicine median Middle half National median
2019 $987,535 $159 $48–$570 $163
2020 $958,634 $119 $33–$402 $114
2021 $954,938 $135 $37–$521 $132
2022 $608,430 $141 $42–$496 $149
2023 $653,902 $149 $45–$519 $160
2024 $654,479 $154 $47–$537 $164
2025 $80,156 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vertex Pharmaceuticals Incorporated $3,258,564 333 payments
  2. Exelixis Inc. $1,639,509 59 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,668,205 29 payments
  2. Current or prospective ownership or investment interest $1,600,422 4 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,523,919 27 payments
  4. Travel and Lodging $81,423 74 payments
  5. Food and Beverage $20,698 252 payments
  6. Gift $3,407 6 payments
Products named General payments · program years 2019–2025
  1. CABOMETYX $17,500 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

392 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record